Tybost (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Tybost drug offered from Gilead Sciences, Inc.. This Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
| NON-PROPRIETARY NAME: | COBICISTAT |
| SUBSTANCE NAME: | COBICISTAT |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-09-24 |
| END MARKETING DATE: | 0000-00-00 |
Tybost HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tybost from Gilead Sciences, Inc. |
| LABELER NAME: | Gilead Sciences, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 2014-09-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61958-1401_a7e53701-1c4c-428e-8df6-61e816c730d5 |
| PRODUCT NDC: | 61958-1401 |
| APPLICATION NUMBER: | NDA203094 |
Other COBICISTAT Pharmaceutical Manufacturers / Labelers:
